Enterprise Value
1.633B
Cash
446.1M
Avg Qtr Burn
-19.88M
Short % of Float
31.75%
Insider Ownership
22.34%
Institutional Own.
65.36%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
REACT Details Chronic kidney disease | Phase 2/3 Data readout |